Mostrar el registro sencillo del ítem

dc.contributor.author
Haymour, Layla  
dc.contributor.author
Jean, Mickael  
dc.contributor.author
Smulski, Cristian Roberto  
dc.contributor.author
Legembre, Patrick  
dc.date.available
2024-07-22T12:21:40Z  
dc.date.issued
2023-11  
dc.identifier.citation
Haymour, Layla; Jean, Mickael; Smulski, Cristian Roberto; Legembre, Patrick; CD95 (Fas) and CD95L (FasL)-mediated non-canonical signaling pathways; Elsevier Science; Biochimica Et Biophysica Acta-reviews On Cancer; 1878; 6; 11-2023; 1-7  
dc.identifier.issn
0304-419X  
dc.identifier.uri
http://hdl.handle.net/11336/240476  
dc.description.abstract
Although the interaction of CD95L (also known as FasL) with its so-called death receptor CD95 (Fas) induces anapoptotic signal responsible for the elimination of infected and cancer cells and maintenance of tissue homeostasis,this receptor can also implement non apoptotic signaling pathways. This latter signaling is involved inmetastatic dissemination in certain cancers and the severity of auto-immune disorders. The signaling complexityof this pair is increased by the fact that CD95 expression itself seems to contribute to oncogenesis via a CD95Lindependentmanner and, that both ligand and receptor might interact with other partners modulating theirpathophysiological functions. Finally, CD95L itself can trigger cell signaling in immune cells rendering complexthe interpretation of mouse models in which CD95 or CD95L are knocked out. Herein, we discuss these noncanonicalresponses and their biological functions.  
dc.format
application/pdf  
dc.language.iso
eng  
dc.publisher
Elsevier Science  
dc.rights
info:eu-repo/semantics/restrictedAccess  
dc.rights.uri
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/  
dc.subject
CD95  
dc.subject
Ligand-independent signal  
dc.subject
Nf-kB  
dc.subject
Reverse signalling  
dc.subject.classification
Otras Medicina Básica  
dc.subject.classification
Medicina Básica  
dc.subject.classification
CIENCIAS MÉDICAS Y DE LA SALUD  
dc.title
CD95 (Fas) and CD95L (FasL)-mediated non-canonical signaling pathways  
dc.type
info:eu-repo/semantics/article  
dc.type
info:ar-repo/semantics/artículo  
dc.type
info:eu-repo/semantics/publishedVersion  
dc.date.updated
2024-07-19T11:53:25Z  
dc.journal.volume
1878  
dc.journal.number
6  
dc.journal.pagination
1-7  
dc.journal.pais
Países Bajos  
dc.journal.ciudad
Amsterdam  
dc.description.fil
Fil: Haymour, Layla. Universite de Limoges; Francia. Inserm; Francia  
dc.description.fil
Fil: Jean, Mickael. Université de Rennes I. Institut des Sciences Chimiques de Rennes; Francia  
dc.description.fil
Fil: Smulski, Cristian Roberto. Comisión Nacional de Energía Atómica. Centro Atómico Bariloche; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Patagonia Norte; Argentina  
dc.description.fil
Fil: Legembre, Patrick. Universite de Limoges; Francia  
dc.journal.title
Biochimica Et Biophysica Acta-reviews On Cancer  
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.1016/j.bbcan.2023.189004